Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

Ahead of his talk at the 7th Annual Allogeneic Cell Therapies Summit, Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and large-scale ...

AMSBIO (Oxford, UK) has launched GMP-grade StemFit ® for Differentiation, a chemically defined and animal component-free formulation that enables unmatched differentiation of human induced pluripotent ...